1 Matching Annotations
  1. Last 7 days
    1. T090M/280.010.040.01c.1117C>T, gene conversion (c.3931C>T, c.4027A>G, c.4079T>C, c.4105T>A)p.Arg373*, p.Gln1311*, p.Ile1343Val, p.Val1360Ala, p.Phe1369Ile10/28Compound heterozygous

      Case: T090, M, 2

      DiseaseAssertion: VWD type 3

      FamilyInfo: inherited heterozygous gene conversion from the father

      CasePresentingHPOs: n/a

      CaseHPOFreeText: Bleeding Score: 8 (Kruskal–Wallis followed by Mann–Whitney U post-hoc testing Post-hoc testing ), VWF:Ag (IU/ml): 0.01, VWF:RCo (IU/ml): 0.04, FVIII:C (IU/ml): 0.01

      CaseNotHPOs: n/a

      CaseNotHPOFreeText: n/a

      CasePreviousTesting: n/a

      Gene: VWF

      Variant:

      c.1117C>T (p.Arg373*)

      Gene Conversion (

      c.3931C>T (p.Gln1311*)

      c.4027A>G (p.Ile1343Val)

      c.4079T>C (p.Val1360Ala)

      c.4105T>A (p.Phe1369Ile)

      )

      Exon 10/28

      Compound heterozygous

      Note: ELISA-based assay for detecting alloantibodies, genomic analysis via sequencing of leukocytes for the VWF gene including exons 1-52 and about 1.5 km of VWF promoter, PCR amplification for variant confirmation, SALSA-MLPAVWF assay evaluation for partial/total gene deletions when sequencing did not reveal pathogenic explanation